Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 01 Jun 2023 14:36 CEST |
PHOTOCURE | Major shareholder disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 24 May 2023 08:32 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 10 May 2023 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 04 May 2023 13:22 CEST |
PHOTOCURE | Photocure ASA - Correction: Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 18:41 CEST |
PHOTOCURE | Photocure ASA - Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 11:38 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2023 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Apr 2023 16:01 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2022 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 12 Apr 2023 16:01 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 3 May 2023 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2023 08:09 CEST |
PHOTOCURE | Major shareholder disclosure - Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 04 Apr 2023 13:55 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 30 Mar 2023 10:48 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2023 21:57 CET |
PHOTOCURE | Photocure provides update on Karl Storz's commitment to maximize the commercial adoption of SaphiraT and decision to discontinue flexible BLC tower production in the U.S. | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Mar 2023 08:00 CET |
PHOTOCURE | Photocure: New data presented at EAU 2023 highlight the effects of blue light cystoscopy in bladder cancer | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 24 Feb 2023 15:57 CET |
PHOTOCURE | NOTIFICATION OF MAJOR HOLDINGS | 20103015 Pharmaceuticals | Major shareholding notifications |
| 24 Feb 2023 08:17 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 23 Feb 2023 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2022 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Feb 2023 07:30 CET |
PHOTOCURE | Clinical data presented at ASCO GU demonstrates reduced risk of recurrence in non-muscle invasive bladder cancer with the use of BLC | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 16 Feb 2023 13:02 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2022 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 03 Jan 2023 07:30 CET |
PHOTOCURE | New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 Dec 2022 09:23 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Dec 2022 16:50 CET |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 05 Dec 2022 07:30 CET |
PHOTOCURE | New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 15 Nov 2022 14:08 CET |
PHOTOCURE | Major shareholder disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 07 Nov 2022 07:30 CET |
PHOTOCURE | Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance setting | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Nov 2022 10:36 CET |
PHOTOCURE | Photocure Partner Asieris announces 1[st] Patient enrolled in Hexvix Phase III trial in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 03 Nov 2022 14:53 CET |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 02 Nov 2022 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2022 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 25 Oct 2022 08:44 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2022 financial results | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 10 Oct 2022 14:43 CEST |
PHOTOCURE | Major shareholder disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 28 Sep 2022 07:30 CEST |
PHOTOCURE | Photocure Announces the Commercial Availability of Karl Storz's New Blue Light System in the U.S. | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 26 Sep 2022 08:19 CEST |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 20 Sep 2022 07:30 CEST |
PHOTOCURE | New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesia | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 15 Sep 2022 09:36 CEST |
PHOTOCURE | Photocure Partner Asieris announces coverage of Hexvix by the Lecheng Global Specialty Drug Insurance | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 Sep 2022 07:30 CEST |
PHOTOCURE | Bladder Cancer technology: New KARL STORZ Blue Light Cystoscopy system featured during E-Masterclass in Urology | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 01 Sep 2022 07:30 CEST |
PHOTOCURE | Photocure appoints Anders Neijber, MD, PhD as Chief Medical Officer, Global Medical Affairs and Clinical Development | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 10 Aug 2022 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the second quarter of 2022 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 09 Aug 2022 09:38 CEST |
PHOTOCURE | Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Aug 2022 15:02 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of second quarter and first half year 2022 financial results | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Jul 2022 14:16 CEST |
PHOTOCURE | Photocure Provides Update on Anticipated Commercial Availability of Karl Storz's New Blue Light System in the United States | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Jul 2022 11:46 CEST |
PHOTOCURE | Photocure ASA – Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 05 Jul 2022 07:30 CEST |
PHOTOCURE | Photocure Collaborations at EAU Support the Latest Advancements in Bladder Cancer Technology | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 13 Jun 2022 08:10 CEST |
PHOTOCURE | Photocure ASA: Share capital increase registered | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Jun 2022 07:30 CEST |
PHOTOCURE | Positive Data from the Danish National Patient Registry presented at the 2022 Nordic Urologisk Forening (NUF) Congress in Helsinki | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 03 Jun 2022 09:00 CEST |
PHOTOCURE | Photocure ASA: Exercise of employee share options | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 03 Jun 2022 08:46 CEST |
PHOTOCURE | Photocure ASA: Acquisition of own shares under the share buy-back program for incentive scheme | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 01 Jun 2022 14:24 CEST |
PHOTOCURE | Photocure ASA: Exercise of employee share options and share capital increase | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 01 Jun 2022 14:14 CEST |
PHOTOCURE | Photocure ASA - Initiation of a share buyback | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 18 May 2022 07:30 CEST |
PHOTOCURE | Blue Light Cystoscopy continues to make news at AUA 2022 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 11 May 2022 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2022 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 05 May 2022 08:45 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2022 financial results | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |